Pediatric Devic's neuromyelitis optica

被引:0
|
作者
Jeffrey, AR [1 ]
Buncic, JR [1 ]
机构
[1] UNIV TORONTO,HOSP SICK CHILDREN,DEPT OPHTHALMOL,TORONTO,ON M5G 1X8,CANADA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: Neuromyelitis optica (Devic's disease) is a rare clinical syndrome of unilateral or bilateral optic neuritis (ON) and transverse myelitis (TM) occurring within an 8-week time interval. All reports mainly involve adults and describe a poor neurologic and ophthalmic clinical course without specific attention to their few pediatric cases. The purpose of this study was to develop a clinical profile in the pediatric population. Methods: A retrospective chart review over 15 years revealed nine cases of neuromyelitis optica. A literature search was undertaken and all cases of pediatric neuromyelitis optica were tabulated and analyzed separately. Results: The average age of onset was 7 years with a preceding Viral prodrome in ail patients. The optic neuritis was bilateral in eight of nine patients (89%). Visual loss ranged from 20/30 to light perception. Moderate anterior disc edema was seen in all 17 affected eyes. The clinical course was characterized by a rapid visual and neurologic recovery. The average follow up was 5.3 years, with five patients followed for 6 years or longer. None of the nine patients had any visual or neurologic recurrence or other significant subsequent illness. Visual system follow up showed 20/20 in each eye of all patients with mild optic atrophy, identified in 47% of eyes. Conclusions: Devic's neuromyelitis optica occurs in the pediatric population as a distinct clinical entity with an excellent prognosis for visual and systemic recovery and no future recurrence or long-term sequelae.
引用
收藏
页码:223 / 229
页数:7
相关论文
共 50 条
  • [21] The clinical course of neuromyelitis optica (Devic's syndrome)
    Wingerchuk, DM
    Hogancamp, WF
    O'Brien, PC
    Weinshenker, BG
    NEUROLOGY, 1999, 53 (05) : 1107 - 1114
  • [22] Immune agents for the treatment of Devic's neuromyelitis optica
    Bergamaschi, R.
    NEUROLOGICAL SCIENCES, 2007, 28 (05) : 238 - 240
  • [23] Treatment of neuromyelitis optica (Devic's disease) with plasmapheresis
    Patil, M
    Friedman, MT
    TRANSFUSION, 2005, 45 (03) : 37A - 38A
  • [24] Cerebrospinal fluid findings in Devic’s neuromyelitis optica
    M. Zaffaroni
    Neurological Sciences, 2004, 25 : s368 - s370
  • [25] Neuromyelitis optica (Devic's disease) in a patient with syphilis
    Wilcox, Robert A.
    Burrow, James
    Slee, Mark
    Craig, Jamie
    Thyagarajan, Dominic
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (02) : 268 - 271
  • [26] Devic's neuromyelitis optica:: study of nine cases
    Fardet, L
    Généreau, T
    Mikaeloff, Y
    Fontaine, B
    Seilhean, D
    Cabane, J
    ACTA NEUROLOGICA SCANDINAVICA, 2003, 108 (03): : 193 - 200
  • [27] Devic's neuromyelitis optica: a primary autoimmune disease?
    Hutchinson, D
    Solomon, T
    Moots, RJ
    RHEUMATOLOGY, 2000, 39 (02) : 215 - 216
  • [28] Neuroradiological aspect of Devic's neuromyelitis optica.
    Bonnan, M
    Olindo, S
    Signate, A
    Khaddam, S
    Caparros-Lefebvre, D
    Smadja, D
    Cabre, P
    REVUE NEUROLOGIQUE, 2006, 162 (05) : 595 - 602
  • [29] Characteristics of Devic's disease (neuromyelitis optica) in Mexico
    J. F. Rivera
    J. F. Kurtzke
    V. J. A. Booth
    T. Corona
    Journal of Neurology, 2008, 255 : 710 - 715
  • [30] Diagnosis and classification of neuromyelitis optica (Devic's Syndrome)
    Drori, Tali
    Chapman, Joab
    AUTOIMMUNITY REVIEWS, 2014, 13 (4-5) : 531 - 533